Study Details

Back
Study ID 3550-CL-0009
Study Title ASP3550 Phase II Study - A Maintenance-Dose-Finding Study of Three-Month Depot in Patients with Prostate Cancer -
Clinicaltrials.gov Identifier NCT01261572
Compound Name ASP3550 / degarelix acetate
Medical Indication or Disease Prostate cancer
Study Sponsor Astellas Pharma Inc.
Collaborator Not Applicable
Study Start Date 12-Oct-2010
Study Completion Date 24-Apr-2012
Clinical Study Result
Select the language
English
Plain Language Summary
Select the language
Japanese

QUICK SEARCH

USEFUL LINKS